Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

AMGN

AMGEN Inc.

May 02 • 04:00PM ET

278.39

Dollar change +1.02
Percentage change 0.37	%

Healthcare • Drug Manufacturers - General • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO QQQ SCHD IVV VTV VIG IBB VYM VHT

Scroll to Statements

Index	DJIA, NDX, S&P 500	P/E	39.81	EPS (ttm)	6.99	Insider Own	0.24%	Shs Outstand	535.40M	Perf Week	3.34%
Market Cap	149.19B	Forward P/E	13.32	EPS next Y	20.89	Insider Trans	-0.93%	Shs Float	534.62M	Perf Month	1.45%
Income	3.76B	PEG	7.59	EPS next Q	4.98	Inst Own	78.11%	Short Float	1.89%	Perf Quarter	-14.23%
Sales	29.40B	P/S	5.07	EPS this Y	4.51%	Inst Trans	-1.47%	Short Ratio	3.45	Perf Half Y	8.87%
Book/sh	9.37	P/B	29.71	EPS next Y	7.20%	ROA	4.14%	Short Interest	10.11M	Perf Year	17.98%
Cash/sh	18.11	P/C	15.37	EPS next 5Y	5.25%	ROE	72.57%	52W Range	211.71 - 329.72	Perf YTD	-3.34%
Dividend Est.	9.30 (3.34%)	P/FCF	20.27	EPS past 5Y	-0.22%	ROI	5.78%	52W High	-15.57%	Beta	0.58
Dividend TTM	8.64 (3.10%)	Quick Ratio	0.98	Sales past 5Y	3.42%	Gross Margin	83.34%	52W Low	31.50%	ATR (14)	5.37
Dividend Ex-Date	May 16, 2024	Current Ratio	1.42	EPS Y/Y TTM	3.15%	Oper. Margin	29.34%	RSI (14)	57.65	Volatility	2.05% 1.93%
Employees	26700	Debt/Eq	12.75	Sales Y/Y TTM	13.38%	Profit Margin	12.80%	Recom	2.23	Target Price	309.98
Option/Short	Yes / Yes	LT Debt/Eq	11.96	EPS Q/Q	-103.99%	Payout	68.24%	Rel Volume	0.96	Prev Close	277.37
Sales Surprise	-0.06%	EPS Surprise	2.09%	Sales Q/Q	23.03%	Earnings	May 02 AMC	Avg Volume	2.93M	Price	278.39
SMA20	3.23%	SMA50	1.37%	SMA200	1.76%	Trades		Volume	3,177,473	Change	0.37%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320
Dec-19-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$286 → $326
Dec-12-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$256 → $300
Nov-09-23	Initiated	Deutsche Bank	Hold	$240
Nov-02-23	Upgrade	Truist	Hold → Buy	$260 → $320
Oct-20-23	Resumed	JP Morgan	Neutral	$265 → $270
Oct-17-23	Resumed	Morgan Stanley	Equal-Weight	$300
Oct-11-23	Resumed	BofA Securities	Neutral	$290
Sep-06-23	Initiated	HSBC Securities	Buy	$320
Apr-24-23	Reiterated	Oppenheimer	Outperform	$292 → $290
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$275 → $265
Feb-13-23	Reiterated	Truist	Buy	$280 → $260
Nov-18-22	Initiated	Credit Suisse	Underperform	$240
Oct-31-22	Downgrade	Barclays	Equal Weight → Underweight	$234
Oct-11-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$257 → $279
May-23-22	Initiated	SVB Leerink	Mkt Perform	$256
Feb-09-22	Reiterated	Wells Fargo	Equal Weight	$210 → $250
Feb-09-22	Reiterated	Oppenheimer	Outperform	$272 → $285

Show Previous Ratings

Today 05:58AM	Novo Slides as Amgen Fuels Obesity Drug Competition Fears (Bloomberg)
05:44AM	BMO Capital Adjusts Price Target on Amgen to $355 From $336, Keeps Outperform Rating (MT Newswires)
05:43AM	RBC Adjusts Price Target on Amgen to $328 From $332, Keeps Outperform Rating (MT Newswires)
05:43AM	Morgan Stanley Adjusts Price Target on Amgen to $310 From $271, Keeps Equalweight Rating (MT Newswires)
05:42AM	Goldman Sachs Adjusts Price Target on Amgen to $350 From $359, Keeps Buy Rating (MT Newswires)
05:42AM	Loading…
05:42AM	Amgen shares jump after teasing 'encouraging' weight loss data (Reuters)
05:41AM	Barclays Upgrades Amgen to Equalweight From Underweight, Adjusts Price Target to $300 From $230 (MT Newswires)
05:28AM	These Stocks Are Moving the Most Today (Barrons.com)
05:27AM	These Stocks Are Moving the Most Today: Apple, Amgen, Expedia, Block, Coinbase, Cloudflare, Fortinet, and More (Barrons.com)
05:18AM	Amgen Stock Jumps on Obesity Drug Optimism. What Comes Next. (Barrons.com)
05:08AM	Amgen soars as CEO gives update on experimental obesity drug (Bloomberg)
03:57AM	Amgen Inc (AMGN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic Advances (GuruFocus.com)
May-02-24 10:10PM	Amgen Stock Surges After Q1 Earnings Beat, 'Encouraging' Weight-Loss Drug Update (Investopedia)
08:59PM	AMGN Stock Earnings: Amgen Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:55PM	Amgen Is 'Very Encouraged' With Its Obesity Study; Shares Rocket 13% (Investor's Business Daily)
06:00PM	Loading…
06:00PM	Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings (Zacks)
05:50PM	Amgen axes obesity asset after phase 1 results, zooms in on MariTide (FierceBiotech.com)
05:42PM	Amgen Inc (AMGN) Q1 2024 Earnings: Aligns with EPS Projections Amid Revenue Growth and Challenges (GuruFocus.com)
05:21PM	Amgen, DraftKings, Live Nation: Trending tickers (Yahoo Finance Video)
04:45PM	Amgen Q1 Non-GAAP Earnings Decline, Revenue Increases; Adjusts Full-Year Guidance; Shares Advance After Hours (MT Newswires)
04:33PM	UPDATE 1-Amgen first-quarter profit dips 1%, revenue rises 22% (Reuters)
04:24PM	Amgen Surges On Strong First-Quarter Profit As Obesity Space Heats Up (Investor's Business Daily)
04:24PM	Amgen Beats First-Quarter Expectations, But Shares Slide As Investors Watch Obesity Space (Investor's Business Daily)
04:09PM	Amgen: Q1 Earnings Snapshot (Associated Press Finance)
04:02PM	Amgen 'encouraged' by weight-loss drug interim data, shares jump (Reuters)
04:01PM	Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma (Business Wire)
04:01PM	AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
04:01PM	Amgen first-quarter profit dips 1%, revenue rises 22% (Reuters)
May-01-24 03:00PM	Ticking Time Bombs: 3 Dow Stocks to Dump While You Still Can (InvestorPlace)
11:11AM	Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:04AM	Loading…
07:04AM	Amgen investors await weight-loss drug data (Reuters)
07:00AM	AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024 (PR Newswire)
Apr-30-24 01:54PM	Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab (Benzinga)
12:05PM	Microsoft Corporation (NASDAQ:MSFT) Q3 2024 Earnings Call Transcript (Insider Monkey)
09:20AM	Sector Update: Health Care Stocks Mixed Premarket Tuesday (MT Newswires)
05:58AM	Amgen Reaches Deal to Resolve Patent Disputes With Sandoz (MT Newswires)
01:28AM	Sandoz reaches agreement with Amgen over patent dispute (Reuters)
Apr-29-24 04:00PM	AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS (PR Newswire)
12:35PM	What's in the Cards for Amgen (AMGN) This Earnings Season? (Zacks)
09:16AM	Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key Metrics (Zacks)
Apr-28-24 08:00AM	What To Expect in the Markets This Week (Investopedia)
Apr-26-24 06:17PM	A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed (Investor's Business Daily)
11:00AM	Amgen to Submit Thyroid Eye Disease Treatment Marketing Authorization Application in Europe (MT Newswires)
09:00AM	AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY (PR Newswire)
Apr-25-24 01:30PM	CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript (Insider Monkey)
11:34AM	20 Fastest Growing Health Tech Companies in the World (Insider Monkey)
10:02AM	Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-22-24 05:50PM	Why Amgen (AMGN) Outpaced the Stock Market Today (Zacks)
11:10AM	10 Best Performing Biotech ETFs in 2024 (Insider Monkey)
Apr-19-24 07:14AM	The Dividend Goldmine: 3 Shining Stocks With Growing Payouts (InvestorPlace)
Apr-17-24 06:00PM	Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
08:00AM	Sell These 3 Blue-Chip Stocks Before the Next Earnings Stumble (InvestorPlace)
08:00AM	Coming FDA Approvals Could Send These 3 Drug Stocks Soaring (InvestorPlace)
07:30AM	Can This High-Yield Dividend Stock Keep Beating the S&P 500? (Motley Fool)
04:30AM	Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever (Motley Fool)
Apr-16-24 05:26PM	AMGEN TO PRESENT TEZSPIRE PHASE 2A COPD DATA AT ATS 2024 (PR Newswire)
04:30PM	The 3 Best Biotech Stocks to Buy Now: Q2 Edition (InvestorPlace)
Apr-15-24 03:07PM	3 Stocks to Buy Low Today With High Hopes for Tomorrow (InvestorPlace)
09:07AM	Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Apr-13-24 12:18PM	Jim Cramer's 10 Favorite Healthcare Stock Picks in 2024 (Insider Monkey)
Apr-12-24 02:48PM	Final Trades: Shell, 2-YR T-Note and Amgen (CNBC TV)
Apr-11-24 06:00PM	Amgen (AMGN) Laps the Stock Market: Here's Why (Zacks)
08:00AM	Is Amgen Stock a Buy? (Motley Fool)
Apr-10-24 03:30PM	Insiders are Piling into These 10 Healthcare Stocks in 2024 (Insider Monkey)
09:27AM	This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives? (MarketWatch)
Apr-09-24 07:37AM	11 Best Biotech ETFs To Buy (Insider Monkey)
07:00AM	3 High-Growth Biotech Stocks Investors Shouldnt Sleep On in April (InvestorPlace)
Apr-07-24 02:00PM	The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024 (InvestorPlace)
07:07AM	Manager of long/short mutual fund touts Amgen (TheStreet)
07:07AM	Fund manager of $100 million long/short mutual fund explains pair trade strategy (TheStreet)
Apr-06-24 08:47PM	10 Best Weight Loss Drug Stocks to Buy Now (Insider Monkey)
07:01PM	13 Best Cheap Dividend Stocks To Buy Right Now (Insider Monkey)
08:45AM	2 Biotech Stocks to Buy Hand Over Fist in April (Motley Fool)
Apr-05-24 05:50PM	Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
04:05AM	3 Stocks to Consider Adding to Your Retirement Portfolio in April (Motley Fool)
Apr-04-24 07:38AM	Merck puts KRAS cancer drug competitor to the test (BioPharma Dive)
Apr-03-24 11:14AM	Here's Why Amgen (AMGN) Stock is Outperforming the Industry (Zacks)
Apr-01-24 06:00PM	Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
12:10PM	Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again (Zacks)
Mar-30-24 03:52PM	11 Oversold Blue Chip Stocks to Buy Right Now (Insider Monkey)
Mar-29-24 09:00AM	Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:05AM	Bristol Myers says KRAS drug succeeds in key trial (BioPharma Dive)
Mar-27-24 01:07PM	3 Biotech Stocks to Buy on the Dip: March 2024 (InvestorPlace)
06:00AM	7 Dow Stocks to Buy on the Dip: March 2024 (InvestorPlace)
Mar-25-24 05:50PM	Amgen (AMGN) Ascends While Market Falls: Some Facts to Note (Zacks)
01:05PM	Buffetts Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating (InvestorPlace)
Mar-24-24 10:58AM	Amgen is coming for Novo Nordisk and Eli Lilly in the weigh loss drug race (Quartz)
10:42AM	16 Most Undervalued Large Cap Stocks To Buy According To Analysts (Insider Monkey)
Mar-21-24 05:29PM	Hot Stocks: The 3 Best Opportunities for Investing in Biotech (InvestorPlace)
07:00AM	Is Amgen Stock a Buy Now? (Motley Fool)
Mar-20-24 03:46PM	Hot Stocks: The 3 Best Opportunities for Investing in the Dow (InvestorPlace)
12:39AM	Acelyrin adds proof-of-concept TED data to recent readout pile, cementing challenge to Amgen (FierceBiotech.com)
Mar-19-24 05:50PM	Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
08:32AM	Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-18-24 06:00PM	Why Amgen (AMGN) Outpaced the Stock Market Today (Zacks)
09:00AM	Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know (Zacks)
Mar-14-24 09:37AM	5 Most Profitable Biotech Stocks To Invest In (Insider Monkey)
09:26AM	13 Most Undervalued Blue Chip Stocks To Buy According To Analysts (Insider Monkey)
Mar-12-24 08:30AM	CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:46AM	Q4 2023 CytomX Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	Dec 04 '23	Sale	273.03	2,096	572,276	10,874	Dec 04 07:41 PM
Graham Jonathan P	EVP, Gen. Counsel & Secy.	Nov 08 '23	Sale	272.81	10,000	2,728,136	28,078	Nov 13 08:30 PM
AMGEN INC	10% Owner	Sep 19 '23	Buy	17.00	1,764,705	29,999,985	35,368,653	Sep 19 07:52 PM
Gordon Murdo	EVP, Global Commercial Ops	Aug 10 '23	Sale	262.43	9,558	2,508,306	44,308	Aug 11 06:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc.

Upgrade your FINVIZ experience